Cosmeceuticals: Practical Applications

Dermatologic Clinics

Volumn 27, Issue 4, 2009, Pages 401-416

  Reszko, Anetta E ^a   Berson, Diane ^a,b   Lupo, Mary P ^c  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Tulane Medical School ^*  (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti inflammatory; Antioxidants; Cosmeceuticals; Peptides; Pigment lightening; Procedure protocols; Vitamins

Indexed keywords

ADAPALENE; ALPHA TOCOPHEROL; ANTIBIOTIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ARBUTIN; ASCORBIC ACID; AZELAIC ACID; COLLAGEN; CORTICOSTEROID; COSMETIC; DEOXYARBUTIN; DEPIGMENTING AGENT; EDELWEISS COMPLEX; ELLAGIC ACID; EMODIN; FATTY ACID; GLYCYRRHIZA GLABRA EXTRACT; HYDROQUINONE; IMMUNOMODULATING AGENT; KOJIC ACID; LICOCHALCONE A; NICOTINAMIDE; PLACEBO; PYCNOGENOL; RETINOIC ACID; SALICYLIC ACID; SIGNAL PEPTIDE; SUNSCREEN; TRI LUMA; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ALOE VERA; CHLOASMA; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG APPROVAL; DRUG EFFICACY; DRUG INDICATION; DRUG POTENTIATION; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYDRATION; HYPERPIGMENTATION; MONOTHERAPY; NONHUMAN; OCHRONOSIS; PHOTOAGING; PHOTOSENSITIVITY; PRIORITY JOURNAL; REVIEW; ROSACEA; SIDE EFFECT; SKIN ABRASION; SKIN IRRITATION; SKIN SENSITIZATION; SUNLIGHT PROTECTION; TREATMENT DURATION; TREATMENT INDICATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; UNSPECIFIED SIDE EFFECT;

COSMETICS; HUMANS; SKIN AGING; SKIN PIGMENTATION;

EID: 70350007174     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2009.08.005     Document Type: Review

References (116)

1. Kligman A. The future of cosmeceuticals: an interview with Albert Kligman, MD, PhD. Interview by Zoe Diana Draelos. Dermatol Surg 31 7 Pt 2 (2005) 890-891
2. Lupo M.P., and Cole A.L. Cosmeceutical peptides. Dermatol Ther 20 5 (2007) 343-349
3. Choi C.M., and Berson D.S. Cosmeceuticals. Semin Cutan Med Surg 25 3 (2006) 163-168
4. Berson D.S. Natural antioxidants. J Drugs Dermatol 7 7 Suppl (2008) s7-12
5. Draelos Z.D. Skin lightening preparations and the hydroquinone controversy. Dermatol Ther 20 5 (2007) 308-313
6. Draelos Z.D. The cosmeceutical realm. Clin Dermatol 26 6 (2008) 627-632
7. Draelos Z.D. Topical agents used in association with cosmetic surgery. Semin Cutan Med Surg 18 2 (1999) 112-118
8. Lawrence N., Bligard C.A., Reed R., et al. Exogenous ochronosis in the United States. J Am Acad Dermatol 18 5 Pt 2 (1988) 1207-1211
9. Westerhof W., and Kooyers T.J. Hydroquinone and its analogues in dermatology - a potential health risk. J Cosmet Dermatol 4 2 (2005) 55-59
10. Fitton A., and Goa K.L. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 41 5 (1991) 780-798
11. Balina L.M., and Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30 12 (1991) 893-895
12. Bissett D. Topical niacinamide and barrier enhancement. Cutis 70 6 Suppl (2002) 8-12
13. Bissett D.L., Oblong J.E., and Berge C.A. Niacinamide: A B vitamin that improves aging facial skin appearance. Dermatol Surg 31 7 Pt 2 (2005) 860-865
14. Greatens A., Hakozaki T., Koshoffer A., et al. Effective inhibition of melanosome transfer to keratinocytes by lectins and niacinamide is reversible. Exp Dermatol 14 7 (2005) 498-508
15. Bissett D.L., Robinson L.R., Raleigh P.S., et al. Reduction in the appearance of facial hyperpigmentation by topical N-acetyl glucosamine. J Cosmet Dermatol 6 1 (2007) 20-26
16. Amer M., and Metwalli M. Topical liquiritin improves melasma. Int J Dermatol 39 4 (2000) 299-301
17. Yokota T., Nishio H., Kubota Y., et al. The inhibitory effect of glabridin from licorice extracts on melanogenesis and inflammation. Pigment Cell Res 11 6 (1998) 355-361
18. Hori I., Nihei K., and Kubo I. Structural criteria for depigmenting mechanism of arbutin. Phytother Res 18 6 (2004) 475-479
19. Hamed S.H., Sriwiriyanont P., deLong M.A., et al. Comparative efficacy and safety of deoxyarbutin, a new tyrosinase-inhibiting agent. J Cosmet Sci 57 4 (2006) 291-308
20. Choi S., Lee S.K., Kim J.E., et al. Aloesin inhibits hyperpigmentation induced by UV radiation. Clin Exp Dermatol 27 6 (2002) 513-515
21. Jones K., Hughes J., Hong M., et al. Modulation of melanogenesis by aloesin: a competitive inhibitor of tyrosinase. Pigment Cell Res 15 5 (2002) 335-340
22. Wang Z., Li X., Yang Z., et al. Effects of aloesin on melanogenesis in pigmented skin equivalents. Int J Cosmet Sci 30 2 (2008) 121-130
23. Lazou K., Sadick N.S., Kurfurst R., et al. The use of antisense strategy to modulate human melanogenesis. J Drugs Dermatol 6 6 Suppl (2007) s2-s7
24. Lee G.S. Intravenous vitamin C in the treatment of post-laser hyperpigmentation for melasma: a short report. J Cosmet Laser Ther 10 4 (2008) 234-236
25. Soliman M.M., Ramadan S.A., Bassiouny D.A., et al. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study. J Cosmet Dermatol 6 2 (2007) 89-94
26. Espinal-Perez L.E., Moncada B., and Castanedo-Cazares J.P. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma. Int J Dermatol 43 8 (2004) 604-607
27. Kaidbey K.H., Kligman A.M., and Yoshida H. Effects of intensive application of retinoic acid on human skin. Br J Dermatol 92 6 (1975) 693-701
28. Kligman A.M., and Willis I. A new formula for depigmenting human skin. Arch Dermatol 111 1 (1975) 40-48
29. Gupta A.K., Gover M.D., Nouri K., et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 55 6 (2006) 1048-1065
30. Griffiths C.E., Finkel L.J., Ditre C.M., et al. Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. Br J Dermatol 129 4 (1993) 415-421
31. Rahman Z., Alam M., and Dover J.S. Fractional laser treatment for pigmentation and texture improvement. Skin Therapy Lett 11 9 (2006) 7-11
32. Goldberg D.J., Berlin A.L., and Phelps R. Histologic and ultrastructural analysis of melasma after fractional resurfacing. Lasers Surg Med 40 2 (2008) 134-138
33. Tannous Z.S., and Astner S. Utilizing fractional resurfacing in the treatment of therapy-resistant melasma. J Cosmet Laser Ther 7 1 (2005) 39-43
34. Rokhsar C.K., and Fitzpatrick R.E. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 31 12 (2005) 1645-1650
35. Kunachak S., Leelaudomlipi P., and Wongwaisayawan S. Dermabrasion: a curative treatment for melasma. Aesthetic Plast Surg 25 2 (2001) 114-117
36. Grimes P.E. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 25 1 (1999) 18-22
37. Erbil H., Sezer E., Tastan B., et al. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma. J Dermatol 34 1 (2007) 25-30
38. Lim J.T., and Tham S.N. Glycolic acid peels in the treatment of melasma among Asian women. Dermatol Surg 23 3 (1997) 177-179
39. Reszko A.E., and Granstein. Pathogenesis of rosacea. J Cosmet Dermatol 21 4 (2008) 224-232
40. Weber T.M., Ceilley R.I., Buerger A., et al. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A. J Cosmet Dermatol 5 3 (2006) 227-232
41. Kolbe L., Immeyer J., Batzer J., et al. Anti-inflammatory efficacy of Licochalcone A: correlation of clinical potency and in vitro effects. Arch Dermatol Res 298 1 (2006) 23-30
42. Del Rosso J.Q. The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. Cutis 77 2 Suppl (2006) 22-24
43. Bedi M.K., and Shenefelt P.D. Herbal therapy in dermatology. Arch Dermatol 138 2 (2002) 232-242
44. Syed T.A., Ahmad S.A., Holt A.H., et al. Management of psoriasis with aloe vera extract in a hydrophilic cream: a placebo-controlled, double-blind study. Trop Med Int Health 1 4 (1996) 505-509
45. Brown D.J., and Dattner A.M. Phytotherapeutic approaches to common dermatologic conditions. Arch Dermatol 134 11 (1998) 1401-1404
46. Albring M., Albrecht H., Alcorn G., et al. The measuring of the antiinflammatory effect of a compound on the skin of volunteers. Methods Find Exp Clin Pharmacol 5 8 (1983) 575-577
47. Wu J. Anti-inflammatory ingredients. J Drugs Dermatol 7 7 Suppl (2008) s13-s16
48. Martin K., Sur R., Liebel F., et al. Parthenolide-depleted feverfew (Tanacetum parthenium) protects skin from UV irradiation and external aggression. Arch Dermatol Res 300 2 (2008) 69-80
49. FDA, Department of Health and Human Services [HHS]. Skin protectant drug products for over-the-counter human use; final monograph. Final rule. Fed Regist 68 33 (2003) 362-381
50. Kurtz E.S., and Wallo W. Colloidal oatmeal: history, chemistry and clinical properties. J Drugs Dermatol 6 2 (2007) 167-170
51. Torras M.A., Faura C.A., Schonlau F., et al. Antimicrobial activity of Pycnogenol. Phytother Res 19 7 (2005) 647-648
52. Sime S., and Reeve V.E. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem Photobiol 79 2 (2004) 193-198
53. Rohdewald P. A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40 4 (2002) 158-168
54. Saliou C., Rimbach G., Moini H., et al. Solar ultraviolet-induced erythema in human skin and nuclear factor-kappa-B-dependent gene expression in keratinocytes are modulated by a French maritime pine bark extract. Free Radic Biol Med 30 2 (2001) 154-160
55. Andreassi M., Stanghellini E., Ettorre A., et al. Antioxidant activity of topically applied lycopene. J Eur Acad Dermatol Venereol 18 1 (2004) 52-55
56. Offord E.A., Gautier J.C., Avanti O., et al. Photoprotective potential of lycopene, beta-carotene, vitamin E, vitamin C and carnosic acid in UVA-irradiated human skin fibroblasts. Free Radic Biol Med 32 12 (2002) 1293-1303
57. Pinnell S.R. Cutaneous photodamage, oxidative stress, and topical antioxidant protection. J Am Acad Dermatol 48 1 (2003) 1-19
58. Singh R.P., and Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal 4 4 (2002) 655-663
59. Katiyar S.K., Roy A.M., and Baliga M.S. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther 4 2 (2005) 207-216
60. Katiyar S.K. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects. [review]. Int J Oncol 26 1 (2005) 169-176
61. Berardesca E., Cameli N., Cavallotti C., et al. Combined effects of silymarin and methylsulfonylmethane in the management of rosacea: clinical and instrumental evaluation. J Cosmet Dermatol 7 1 (2008) 8-14
62. Erden I.M., Kahraman A., and Koken T. Beneficial effects of quercetin on oxidative stress induced by ultraviolet A. Clin Exp Dermatol 26 6 (2001) 536-539
63. Piantelli M., Maggiano N., Ricci R., et al. Tamoxifen and quercetin interact with type II estrogen binding sites and inhibit the growth of human melanoma cells. J Invest Dermatol 105 2 (1995) 248-253
64. Thornfeldt C. Cosmeceuticals containing herbs: fact, fiction, and future. Dermatol Surg 31 7 Pt 2 (2005) 873-880
65. Taub A.F. Procedural treatments for acne vulgaris. Dermatol Surg 33 9 (2007) 1005-1026
66. Kessler E., Flanagan K., Chia C., et al. Comparison of alpha- and beta-hydroxy acid chemical peels in the treatment of mild to moderately severe facial acne vulgaris. Dermatol Surg 34 1 (2008) 45-50
67. Lee H.S., and Kim I.H. Salicylic acid peels for the treatment of acne vulgaris in Asian patients. Dermatol Surg 29 12 (2003) 1196-1199
68. Corcuff P., Fiat F., Minondo A.M., et al. A comparative ultrastructural study of hydroxyacids induced desquamation. Eur J Dermatol 12 4 (2002) XXXIX-XLIII
69. Uhoda E., Pierard-Franchimont C., and Pierard G.E. Comedolysis by a lipohydroxyacid formulation in acne-prone subjects. Eur J Dermatol 13 1 (2003) 65-68
70. Lowe N.J., Behr K.L., Fitzpatrick R., et al. Flash lamp pumped dye laser for rosacea-associated telangiectasia and erythema. J Dermatol Surg Oncol 17 6 (1991) 522-525
71. Butterwick K.J., Butterwick L.S., and Han A. Laser and light therapies for acne rosacea. J Drugs Dermatol 5 1 (2006) 35-39
72. Yamasaki K., Di N.A., Bardan A., et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 13 8 (2007) 975-980
73. Barak O., Treat J.R., and James W.D. Antimicrobial peptides: effectors of innate immunity in the skin. Adv Dermatol 21 (2005) 357-374
74. Harvey J. Rosacea: molecular insights. Skin Aging 14 (2007)
75. Kosmadaki M.G., and Gilchrest B.A. The role of telomeres in skin aging/photoaging. Micron 35 3 (2004) 155-159
76. Gilchrest B.A. Skin aging and photoaging: an overview. J Am Acad Dermatol 21 3 Pt 2 (1989) 610-613
77. Schwartz E., Cruickshank F.A., Christensen C.C., et al. Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol 58 6 (1993) 841-844
78. Camouse M.M., Hanneman K.K., Conrad E.P., et al. Protective effects of tea polyphenols and caffeine. Expert Rev Anticancer Ther 5 6 (2005) 1061-1068
79. Katiyar S.K., Elmets C.A., Agarwal R., et al. Protection against ultraviolet-B radiation-induced local and systemic suppression of contact hypersensitivity and edema responses in C3H/HeN mice by green tea polyphenols. Photochem Photobiol 62 5 (1995) 855-861
80. Wang Z.Y., Agarwal R., Bickers D.R., et al. Protection against ultraviolet B radiation-induced photocarcinogenesis in hairless mice by green tea polyphenols. Carcinogenesis 12 8 (1991) 1527-1530
81. Vayalil P.K., Mittal A., Hara Y., et al. Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 122 6 (2004) 1480-1487
82. Katiyar S.K., Afaq F., Perez A., et al. Green tea polyphenol (-)-epigallocatechin-3-gallate treatment of human skin inhibits ultraviolet radiation-induced oxidative stress. Carcinogenesis 22 2 (2001) 287-294
83. Elmets C.A., Singh D., Tubesing K., et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J Am Acad Dermatol 44 3 (2001) 425-432
84. Chiu A.E., Chan J.L., Kern D.G., et al. Double-blinded, placebo-controlled trial of green tea extracts in the clinical and histologic appearance of photoaging skin. Dermatol Surg 31 7 Pt 2 (2005) 855-860
85. Fitzpatrick R.E., and Rostan E.F. Double-blind, half-face study comparing topical vitamin C and vehicle for rejuvenation of photodamage. Dermatol Surg 28 3 (2002) 231-236
86. Lin F.H., Lin J.Y., Gupta R.D., et al. Ferulic acid stabilizes a solution of vitamins C and E and doubles its photoprotection of skin. J Invest Dermatol 125 4 (2005) 826-832
87. Baumann L.S. Less-known botanical cosmeceuticals. Dermatol Ther 20 5 (2007) 330-342
88. Farris P. Idebenone, green tea, and coffeeberry extract: new and innovative antioxidants. Dermatol Ther 20 5 (2007) 322-329
89. Ditre C., Wu J., Baumann L.S., et al. Innovations in natural antioxidants and their role in dermatology. Cutis 82 6 Suppl (2008) 2-16
90. McDaniel D., Neudecker B., Dinardo J., et al. Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone. J Cosmet Dermatol 4 3 (2005) 167-173
91. Cornacchione S., Sadick N.S., Neveu M., et al. In vivo skin antioxidant effect of a new combination based on a specific Vitis vinifera shoot extract and a biotechnological extract. J Drugs Dermatol 6 6 Suppl (2007) s8-13
92. Seiberg M., Paine C., Sharlow E., et al. The protease-activated receptor 2 regulates pigmentation via keratinocyte-melanocyte interactions. Exp Cell Res 254 1 (2000) 25-32
93. Wei H., Saladi R., Lu Y., et al. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr 133 11 Suppl 1 (2003) 3811S-3819S
94. Lim H.H., and Buttery J.E. Determination of ethanol in serum by an enzymatic PMS-INT colorimetric method. Clin Chim Acta 75 1 (1977) 9-12
95. Talwar H.S., Griffiths C.E., Fisher G.J., et al. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 105 2 (1995) 285-290
96. Sorg O., Kuenzli S., Kaya G., et al. Proposed mechanisms of action for retinoid derivatives in the treatment of skin aging. J Cosmet Dermatol 4 4 (2005) 237-244
97. Stefanaki C., Stratigos A., and Katsambas A. Topical retinoids in the treatment of photoaging. J Cosmet Dermatol 4 2 (2005) 130-134
98. Singh M., and Griffiths C.E. The use of retinoids in the treatment of photoaging. Dermatol Ther 19 5 (2006) 297-305
99. Serri R., and Iorizzo M. Cosmeceuticals: focus on topical retinoids in photoaging. Clin Dermatol 26 6 (2008) 633-635
100. Mukherjee S., Date A., Patravale V., et al. Retinoids in the treatment of skin aging: an overview of clinical efficacy and safety. Clin Interv Aging 1 4 (2006) 327-348
101. Helfrich Y.R., Sachs D.L., and Voorhees J.J. Overview of skin aging and photoaging. Dermatol Nurs 20 3 (2008) 177-183
102. Monheit G.D., and Chastain M.A. Chemical peels. Facial Plast Surg Clin North Am 9 2 (2001) 239-255 viii
103. Clark E., and Scerri L. Superficial and medium-depth chemical peels. Clin Dermatol 26 2 (2008) 209-218
104. Alexiades-Armenakas M.R., Dover J.S., and Arndt K.A. The spectrum of laser skin resurfacing: nonablative, fractional, and ablative laser resurfacing. J Am Acad Dermatol 58 5 (2008) 719-737
105. Ehrlich M., Rao J., Pabby A., et al. Improvement in the appearance of wrinkles with topical transforming growth factor beta(1) and l-ascorbic acid. Dermatol Surg 32 5 (2006) 618-625
106. Fitzpatrick R.E., and Rostan E.F. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther 5 1 (2003) 25-34
107. Cass D.L., Meuli M., and Adzick N.S. Scar wars: implications of fetal wound healing for the pediatric burn patient. Pediatr Surg Int 12 7 (1997) 484-489
108. Gold M.H., Goldman M.P., and Biron J. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation. J Drugs Dermatol 6 2 (2007) 197-201
109. Tajima S., Wachi H., Uemura Y., et al. Modulation by elastin peptide VGVAPG of cell proliferation and elastin expression in human skin fibroblasts. Arch Dermatol Res 289 8 (1997) 489-492
110. Kamoun A., Landeau J.M., Godeau G., et al. Growth stimulation of human skin fibroblasts by elastin-derived peptides. Cell Adhes Commun 3 4 (1995) 273-281
111. Lintner K. Promoting production in the extracellular matrix without compromising barrier. Cutis 70 6 Suppl (2002) 13-16
112. Katayama K., Armendariz-Borunda J., Raghow R., et al. A pentapeptide from type I procollagen promotes extracellular matrix production. J Biol Chem 268 14 (1993) 9941-9944
113. Robinson L.R., Fitzgerald N.C., Doughty D.G., et al. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skin. Int J Cosmet Sci 27 3 (2005) 155-160
114. Blanes-Mira C., Clemente J., Jodas G., et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci 24 5 (2002) 303-310
115. Pickart L., Freedman J.H., Loker W.J., et al. Growth-modulating plasma tripeptide may function by facilitating copper uptake into cells. Nature 288 5792 (1980) 715-717
116. Buffoni F., Pino R., and Dal P.A. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Arch Int Pharmacodyn Ther 330 3 (1995) 345-360